PainChek secures Hallmark agreement covering all 23 UK care homes
PainChek (ASX: PCK) has secured an agreement with new UK customer Hallmark Luxury Care Homes to introduce PainChek across its entire portfolio of 23 homes in England and Wales. The agreement was announced on 27 October 2026.
The deal adds approximately 1,800 committed resident licences, all new business for PainChek’s UK contracted base. For investors, the announcement describes it as contracted growth with a defined rollout.
Karen Holzberger, CEO of PainChek
“…We have secured a new customer, approximately 1,800 additional resident licences for PainChek, with rollout planned across its entire portfolio.”
When big ASX news breaks, our subscribers know first
How the deal builds on PainChek’s UK footprint
The agreement builds on PainChek’s established UK business. The approximately 1,800 Hallmark licences represent additional contracted business and are not included in the base figures below.
The numbers behind the base
At 30 June 2026, PainChek had 90,198 implemented licences globally, generating A$4.46 million in implemented annual recurring revenue (ARR). The UK accounted for 33,470 implemented licences and A$1.85 million in implemented ARR.
These figures come from PainChek’s June 2026 Quarterly Activities Report, released on 29 July 2026.
UK licence growth had already been building earlier in the year, with 4,000 new contracted licences added in a single quarter and a further $230,000 AUD in annual recurring revenue expected once those licences are implemented.
| Metric | Global | UK (30 June 2026) |
|---|---|---|
| Implemented licences | 90,198 | 33,470 |
| Implemented ARR | A$4.46 million | A$1.85 million |
About Hallmark
Hallmark is a family-run UK provider of residential, nursing and dementia care. It opened its first home in 1997 and now has over 2,500 team members.
The provider is multi-award winning and rated 9.8/10 across all homes on carehome.co.uk by residents and relatives. The contract includes six homes in Wales.
For PainChek, the agreement expands the number of care teams and residents able to use its technology under a single customer relationship.
Why objective pain assessment matters in aged care
Some aged care residents, including those living with dementia, cannot reliably communicate their pain. That makes consistent assessment harder for care teams.
PainChek develops an AI-powered pain assessment and monitoring application for people who cannot reliably self-report pain. Its application combines three components, supported by reporting and analytics:
- AI-assisted facial analysis
- A structured clinical assessment
- The Numerical Rating Scale
Adoption across all 23 homes is intended to support a consistent approach to pain assessment and monitoring, including for residents who cannot reliably communicate their pain.
Julie Rayner, Care Quality, Governance and Compliance Director at Hallmark Luxury Care Homes
“Understanding when a resident is experiencing pain is fundamental to delivering the care they need, particularly when they cannot easily tell us how they feel…”
What happens next for PainChek and Hallmark
The announcement sets out two timing points for the rollout:
- Late January 2027: Implementation is scheduled to commence, supported by staff training across Hallmark’s homes.
- By 30 June 2027: Full rollout across the contracted portfolio is expected.
PainChek’s near-term priority is to deliver implementation and training, support adoption within day-to-day care and establish ongoing use across the contracted portfolio.
The relationship also provides scope to pursue adoption in future Hallmark homes and acquisitions. These are outside the current contract and would require separate agreement.
Statements on implementation, customer adoption and future expansion reflect current expectations and are subject to implementation schedules, customer decisions and other risks and uncertainties. Any expansion beyond the contracted 23 homes remains subject to further agreement.
For readers wanting to see how PainChek’s growth extends beyond the UK, our full explainer on PainChek’s Sabra REIT agreement sets out the REIT-funded model, the per-bed pricing and the potential 20,000-bed North American footprint.
Get Healthcare News Before the Market Moves
Get FREE breaking ASX healthcare news delivered to your inbox within minutes of release, with in-depth analysis already done. Join 20,000+ investors who stay ahead of the market. Click the “Free Alerts” button at Big News Blast to receive alerts the moment market-moving news breaks.